Electromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026.

Business Wire • Oct 27, 2026

Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event.

Business Wire • Sep 9, 2026

Electromed: Contrarian 'Buy' With SmartVest

Electromed's direct-to-patient model, broad payer coverage, and disciplined sales execution support durable SmartVest growth. The bronchiectasis market remains substantially underpenetrated, leaving a long runway for greater HFCWO adoption. Hospital revenue is volatile, but the channel remains small and full-year hospital sales still increased.

Seeking Alpha • Aug 28, 2026

Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript

Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript

Seeking Alpha • Aug 25, 2026

Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results.

Business Wire • Aug 25, 2026

Electromed Announces CEO's Planned Retirement

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed Announces CEO's Planned Retirement.

Business Wire • Aug 25, 2026

Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates

Electromed, Inc. (ELMD) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.25 per share a year ago.

Zacks Investment Research • Aug 25, 2026

Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026.

Business Wire • Aug 11, 2026

4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX

LQDA, FLXS, ELMD and AGX combine low beta, positive price momentum and strong fundamentals to help investors navigate market volatility.

Zacks Investment Research • Jul 10, 2026

Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why

Electromed (ELMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Zacks Investment Research • Jul 6, 2026